Share page on LinkedIn
  1. Home
  2. News & Events

ICON to acquire PRA Health Sciences

Deal creates a world leader in healthcare intelligence and clinical research

Read more
  1. Home
  2. News & Events

ICON supports Pfizer and BioNTech on COVID-19 vaccine trial

Trial capabilities key to enabling agility and speed in global study involving 44,000 subjects

Read the press release
  1. Home
  2. News & Events

Best CRO at the Vaccine Industry Excellence Awards

Recognises ICON’s long-standing vaccine development expertise.

Read the press release
  1. Home
  2. News & Events

ICON launches Accellacare

Global research network offering integrated solutions of patient assessments at site and in-home for decentralised trials

Read the press release

Press Releases

ICON Reports Fourth Quarter and Full Year 2020 Results

ICON to acquire PRA Health Sciences

ICON launches FIRECREST Safety Letters and Site Question Management

ICON plc to present at the 39th Annual JP Morgan Healthcare Conference

ICON supports Pfizer and BioNTech on the investigational COVID-19 vaccine trial

ICON Releases First Environmental, Social and Governance Report

ICON plc to present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference

ICON Reports Third Quarter 2020 Results

BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response

Events

SCOPE 2021

HIV treatments from antiretroviral therapy to vaccines

CTE Decentralised Trials - Digital Week 2021

Cell & Gene Meeting on the Med

Discover how wet lab and imaging biomarker solutions has the potential to transform CNS drug development

BioEquity Europe

European Site Solutions Summit

Biosimilar Medicines Virtual Summit 2021

World Vaccine Congress Washington 2021

Awards

Awards

ICON Press Office Enquiries

ICON Press Office Enquiries

Videos

Videos

Media Articles

Media Articles

What's Happening in ICON